Key result
A 46-year-old man with COVID-19 infection who developed atrial flutter and atrial fibrillation successfully reverted to normal sinus rhythm within 48 hours using amiodarone and atenolol.
Why the study?
COVID-19 has significant potential cardiovascular implications, including cardiac arrhythmias, but individual presentations warrant clinical description.
Case Report (n=1)
No
This case report highlights that COVID-19 infection can present with atrial arrhythmias such as atrial flutter and fibrillation, which can be successfully managed with standard rate and rhythm control strategies.
May support standard agents for COVID-19 AF; hypothesis-generating and should not change practice.
The coronavirus disease-2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) that has significant potential cardiovascular implications for patients. These include myocarditis, acute coronary syndromes, cardiac arrhythmias, cardiomyopathies with heart failure and cardiogenic shock, and venous thromboembolic events. We describe a Caribbean-Black gentleman with COVID-19 infection presenting with atrial arrhythmias, namely, atrial flutter and atrial fibrillation, which resolved with rate and rhythm control strategies, and supportive care.
No takes yet. Share an insight, caveat, or question.
Seecheran et al. (2020) conducted a case report in COVID-19 with atrial arrhythmias (n=1). Amiodarone and atenolol was evaluated on Reversion to normal sinus rhythm. A 46-year-old man with COVID-19 infection who developed atrial flutter and atrial fibrillation successfully reverted to normal sinus rhythm within 48 hours using amiodarone and atenolol.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: